Sharfo, Abdul Wahab M. http://orcid.org/0000-0003-4487-4108
Stieler, Florian
Kupfer, Oskar
Heijmen, Ben J. M.
Dirkx, Maarten L. P.
Breedveld, Sebastiaan
Wenz, Frederik
Lohr, Frank
Boda-Heggemann, Judit
Buergy, Daniel
Funding for this research was provided by:
Elekta
Article History
Received: 27 February 2018
Accepted: 16 April 2018
First Online: 23 April 2018
Ethics approval and consent to participate
: The study was approved by the ethics committee of Heidelberg University, Medical Faculty Mannheim (2016-806R-MA). Written informed consent for scientific usage of clinical data was obtained from all patients.
: Consent for scientific usage of clinical data was obtained from all patients included in the study.
: Erasmus MC Cancer Institute has research collaborations with Accuray Inc., Sunnyvale, USA.AWMS reports grants from Elekta AB, Stockholm, Sweden, during the conduct of the study; FS reports personal fees from Elekta AB, Sweden, outside the submitted work; OK has nothing to disclose; BJMH reports grants from Elekta AB, Stockholm, Sweden, during the conduct of the study; grants from Accuray Inc., Sunnyvale, USA, outside the submitted work; MLPD reports grants from Elekta AB, Stockholm, Sweden, during the conduct of the study; SB reports grants from Elekta AB, Stockholm, Sweden, during the conduct of the study; grants from Accuray Inc., Sunnyvale, USA, outside the submitted work; FW reports research grants and travel support from Elekta, during the conduct of the study; FL has nothing to disclose; JBH reports teaching honoraria from Elekta AB, Stockholm, Sweden, during the conduct of the study; DB reports personal fees from Siemens AG, personal fees from NB Capital ApS, outside the submitted work.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.